Panacea Global Inc (HOML) financial statements (2020 and earlier)

Company profile

Business Address 330 HIGHWAY 7 EAST
RICHMOND HILL, ON L4B 3P8
State of Incorp. NV
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0022000
Cash and cash equivalents0022000
Receivables0      
Prepaid expense and other current assets0
Other current assets 00000 
Other undisclosed current assets0 (1)   (0)
Total current assets:0012000
Noncurrent Assets
Property, plant and equipment0000000
Long-term investments and receivables1111111
Long-term investments1111111
Intangible assets, net (including goodwill)50505050505050
Intangible assets, net (excluding goodwill)50505050505050
Total noncurrent assets:51515151515151
TOTAL ASSETS:51515253515151
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:0000000
Other undisclosed accounts payable and accrued liabilities0000000
Debt   1  2
Due to related parties1111111
Total current liabilities:1112113
Noncurrent Liabilities
Other undisclosed liabilities1111221
Total liabilities:2223334
Stockholders' equity
Stockholders' equity attributable to parent, including:49495051484848
Common stock0000000
Additional paid in capital56565555525251
Accumulated other comprehensive income0000000
Accumulated deficit(7)      
Warrants and rights outstanding      1
Other undisclosed stockholders' equity attributable to parent (7)(5)(5)(4)(4)(5)
Total stockholders' equity:49495051484848
TOTAL LIABILITIES AND EQUITY:51515253515151

Income statement (P&L) ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Revenues 0     
Financial services revenue 0     
Cost of revenue
(Cost of Goods and Services Sold)
    (0)(0) 
Gross profit: 0  (0)(0) 
Operating expenses(1)(1)(0)(1)(0)(0)(0)
Other operating income (expense), net
(Other Expenses)
 (0)00000
Other undisclosed operating loss  (0)(1)  (0)
Operating loss:(1)(2)(0)(1)(0)(0)(0)
Nonoperating income (expense)
(Foreign Currency Transaction gain, before Tax)
0      
Loss from continuing operations before equity method investments, income taxes:(1)(2)(0)(1)(0)(0)(0)
Income (loss) from equity method investments (0)(0)(0)(0)0(0)
Other undisclosed income (loss) from continuing operations before income taxes  (0)0(0)0(0)
Loss from continuing operations before income taxes:(1)(2)(0)(1)(0)(0)(0)
Other undisclosed income from continuing operations   0   
Loss before gain (loss) on sale of properties:(1)(2)(0)(1)(0)(0)(0)
Other undisclosed net loss   (0)   
Net loss:(1)(2)(0)(1)(0)(0)(0)
Other undisclosed net income (loss) attributable to parent(0)0     
Net loss available to common stockholders, diluted:(1)(1)(0)(1)(0)(0)(0)

Comprehensive Income ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Net loss:(1)(2)(0)(1)(0)(0)(0)
Other comprehensive income (loss)(5)0     
Comprehensive loss:(6)(2)(0)(1)(0)(0)(0)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent50(0)0(0)00
Comprehensive loss, net of tax, attributable to parent:(1)(1)(1)(1)(0)(0)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: